[Surface receptors in relation to pathological differences between falciparum and vivax malaria].
Kanbara
Hiroji
H
Institute of Tropical Medicine, Nagasaki University.
D000818:Animals; D000953:Antigens, Protozoan / Q000502:physiology; D006801:Humans; D016778:Malaria, Falciparum / Q000453:epidemiology / Q000469:parasitology* / Q000503:physiopathology*; D016780:Malaria, Vivax / Q000453:epidemiology / Q000469:parasitology* / Q000503:physiopathology*; D008565:Membrane Proteins / Q000502:physiology; D020066:Merozoite Surface Protein 1 / Q000502:physiology; D010963:Plasmodium falciparum / Q000472:pathogenicity*; D010966:Plasmodium vivax / Q000472:pathogenicity*; D015800:Protozoan Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology; D011956:Receptors, Cell Surface
D000953:Antigens, Protozoan; D008565:Membrane Proteins; D020066:Merozoite Surface Protein 1; D015800:Protozoan Proteins; D011956:Receptors, Cell Surface; C090077:apical membrane antigen I, Plasmodium; C085731:erythrocyte membrane protein 1, Plasmodium falciparum; C075483:reticulocyte-binding protein, Plasmodium vivax